1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease

Annals of Clinical Biochemistry

Volumn 48, Issue 2, 2011, Pages 121-125

  Koga, Masafumi ^a   Murai, Jun ^a   Saito, Hiroshi ^a   Mukai, Mikio ^a   Toya, Daishu ^b   Tanaka, Nobuyoshi ^b   Kanehara, Hideo ^b   Bando, Yukihiro ^b   Kasayama, Soji ^c  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^c Nissay Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHRONIC DISEASE; DEOXYGLUCOSE; DIABETES COMPLICATIONS; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

EID: 79953006959     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010053     Document Type: Article

References (25)

1. Munting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969;24:91-9
2. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:688-94 (Pubitemid 14061425)
3. Giampaolo B, Giulio M, Marco Z, Elizabetta B, Andrea F, Emilio P. Prognostic significance of diabetes in patient with cirrhosis. Hepatology 1994;20:119-25
4. Cacciatore L, Cozzolino G, Giardina MG, et al. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 1988;7:185-8
5. Nomura Y, Nanjo K, Miyano M, et al. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 1989;11:177-80
6. Trenti T, Cristani A, Cioni G, Pentore R, Mussini C, Ventura E. Fructosamine and glycated hemoglobin as indices of glycemic control in patiente with liver cirrhosis. Res Clin Lab 1990;20:261-7
7. Subhiyah BW, AI-Hindawi AY. Red cell survival and eplenic accumulation of radiochomium in liver cirrhosis with splenomegaly. Br J Haematol 1967;13:773-8
8. Bianchi R, Miriani G, Pilo A, Toni MG. Serum albumin turnover in liver cirrhosis. J Nucl Biol Med 1974;18:20-9
9. Stefanovic S, Bosnjakovic V, Stajnfl S, Vujnic V, Petric J, Ristic M. Characteristics of albumin turnover in different stages of cirrhosis of liver evaluated by means of radioisotope technique and analog computer analysis. Radiobiol Radiother 1972;13:105-11
10. 1C as a novel indicator for estimation of mean plasma glucose in the patients with chronic liver disease. Diabetes Res Clin Pract 2008;81:258-62
11. Yamanouchi T, Ogata N, Tagaya T, et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 1996;347:1514-8 (Pubitemid 26162642)
12. Yamagishi S, Ohta M. Serum 1,5-anhydro-D-glucitol levels in liver cirrhosis. Acta Diabetol 1998;35:65-6 (Pubitemid 28306258)
13. Bando Y, Tachibana Y, Fukuoka K, Toya T, Tanaka N, Yanagi S. Clinical study of long-term glycemic control makers in patients with chronic liver disease. J Japan Diab Soc 1997;40:17-24
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97
15. Sherlock S. The portal venous system and portal hypertension. In: Sherlock S, Dooley J, eds. Disease of the Liver and Biliary System. Oxford: Blackwell Science, 1993:132-78
16. Rohlfing CL, England JD, Wiedmeyer HM, Tennill A, Little RR, Goldstein DE. Defining the relationship between plasma glucose and HbA1c. Diabetes Care 2002;25:275-8
17. Yamanouchi T, Tachibana Y, Akanuma H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 1992;263:E268-73
18. Kuriyama S, Miwa Y, Fukushima H, et al. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. J Clin Biochem Nutr 2007;40:116-22 (Pubitemid 46623813)
19. Higuchi T, Nakamura T, Uchino H. Enhanced renal clearance of uric acid in hepatic cirrhosis. Isr J Med Sci 1981;17:1015-18 (Pubitemid 12248854)
20. Izumi N, Hasumura Y, Takeuchi J. Hypouricemia and hyperuricosuria as expressions of renal tubular damage in primary biliary cirrhosis. Hepatology 1983;3:719-23 (Pubitemid 13007700)
21. Bairaktari E, Liamis G, Tsolas O, Elisaf M. Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology 2001;33:1365-9 (Pubitemid 32496972)
22. Moriwaki Y, Yamamoto T, Takahashi S, et al. Uric acid transport in Fanconi syndrome with marked renal hypouricemia: analysis using pyrazinamide and benzbromarone. Nephron 1996;74:452-3
23. Koga M, Murai J, Saito H, et al. Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system. Clin Chim Acta 2009;410:70-3
24. Yamanouchi T, Minoda S, Ogata N, et al. Prolonged hyperalimentation as a possible cause of renal tubular dysfunction: evaluation of 1,5-anhydro-D- glucitol resorption and N-acetylglucosaminidase excretion in humans. Clin Sci 1995;88:203-10
25. Derus CL, Levinson DJ, Bowman B, Bengoa JM, Sitrin MD. Altered fractional excretion of uric acid during total parenteral nutrition. J Rheumatol 1987;14:978-81